Implanet S.A. (IMPZY)
Implanet S.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Martillac, NA, FR. The stock last traded at $0.08, up 0.00% on the session, giving a market capitalisation of $230.1M. On trailing twelve-month figures it carries a trailing P/E of -6.21, a net margin of -35.1%. Its beta of 0.63 implies it has historically moved less than the broad market.
Implanet S.A., along with its affiliated entities, focuses on the creation, production, and distribution of medical implants for both spinal and orthopedic applications. The firm's product range encompasses solutions for spinal conditions and knee replacements. Specifically, its spinal offerings feature a variety of posterior fixation systems, including the Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw. For knee patients, Implanet also supplies prosthetic devices under the Madison brand. The company maintains a significant strategic alliance with Shanghai Sanyou Medical Co, Ltd. Established in 2006, Implanet S.A. is based in Martillac, France.
Implanet S.A. is most often compared with the following Healthcare names: